Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CHKA | P35790 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | NCF1 | P14598 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4311811 | 1.00 | TDP1 (0.38) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL12354598 | 1.00 | TDP1 (0.38) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL10179314 | 0.97 | TDP1 (0.37) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL5675656 | 0.97 | TDP1 (0.37) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL17787332 | 0.97 | TDP1 (0.35) | TDP1KDM4EHTTCHKALMNA | |
| Hydrochloric Acid SCHEMBL3998282 | 0.94 | TDP1 (0.35) | TDP1KDM4EHTTCHKALMNA | |
| Hydrochloric Acid SCHEMBL3998279 | 0.94 | HTT (0.39) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL4318497 | 0.89 | CHKA (0.35) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL29875104 | 0.87 | KDM4E (0.32) | TDP1KDM4EHTTCHKALMNA | |
| SCHEMBL29874801 | 0.87 | KDM4E (0.32) | TDP1KDM4EHTTCHKALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 538 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2661473-B1 | ANTISKINNING COMPOSITIONS | OMG UK TECH LIMITED (GB) | 2021-09-15 | — | — | EP | claimed |
| EP-3307940-B1 | OXIDATIVE METHOD | CATEXEL TECH LIMITED (GB) | 2021-03-24 | — | — | EP | claimed |
| EP-3307941-B1 | OXIDATIVE METHOD | CATEXEL TECH LIMITED (GB) | 2021-03-24 | — | — | EP | claimed |
| US-10882745-B2 | Oxidative method | CATEXEL TECHNOLOGIES LIMITED (GB) | 2021-01-05 | — | — | US | claimed |
| US-10815616-B2 | Oxidative method | CATEXEL TECHNOLOGIES LIMITED (GB) | 2020-10-27 | — | — | US | claimed |
| US-20180186634-A1 | OXIDATIVE METHOD | CATEXEL B.V. (NL) | 2018-07-05 | — | — | US | claimed |
| EP-3307940-A1 | OXIDATIVE METHOD | Catexel Technologies Limited (GB) | 2018-04-18 | — | — | EP | claimed |
| EP-3307941-A1 | OXIDATIVE METHOD | Catexel Technologies Limited (GB) | 2018-04-18 | — | — | EP | claimed |
| US-20180094384-A1 | OXIDATIVE METHOD | CATEXEL B.V. (NL) | 2018-04-05 | — | — | US | claimed |
| EP-3024898-B1 | ENCAPSULATED CATALYSTS | OMG UK TECH LTD (GB) | 2017-11-08 | — | — | EP | claimed |
| EP-1631653-B1 | LIQUID BLEACHING COMPOSITION | UNILEVER PLC (GB) | 2007-04-04 | — | — | EP | claimed |
| US-20070004613-A1 | Liquid bleaching composition | CONOPCO, INC., D/B/A UNILEVER | 2007-01-04 | — | — | US | claimed |
| EP-1157088-B1 | STABILIZED BLEACH COMPOSITIONS | PROCTER & GAMBLE (US) | 2006-01-11 | — | — | EP | claimed |
| EP-1129095-B1 | PROCESS FOR PREPARING CROSS-BRIDGED TETRAAZA MACROCYCLES | PROCTER & GAMBLE (US) | 2004-09-15 | — | — | EP | claimed |
| US-6720299-B2 | BLEACH WITH POLYMER COATING | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-04-13 | — | — | US | claimed |
| US-6555681-B1 | Reducing and cleaving an diammonium salt of a tetraaza-tetracyclic compound using a stoichiometric amount of an alkali boron hydride at a pH of 11 to a tetraaza-bicyclic compound; transition metal complexes as bleach catalysts | PROCTER & GAMBLE COMPANY | 2003-04-29 | — | — | US | claimed |
| US-20020173440-A1 | Bleaching composition of enhanced stability and a process for making such a composition | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-11-21 | — | — | US | claimed |
| EP-1129164-A1 | BLEACH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-05 | — | — | EP | claimed |
| WO-2000029537-A1 | BLEACH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-05-25 | — | — | WO | claimed |
| WO-1999005084-A1 | PROCESS FOR MAKING ALKYLBENZENESULFONATE SURFACTANTS FROM ALCOHOLS AND PRODUCTS THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 1999-02-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10815616-B2 | Oxidative method | CAT, LPO, MPO | TDP1 2935/4885KDM4E 3828/4885HTT 2048/4885 |
| US-10882745-B2 | Oxidative method | CAT, LPO, GPX4 | TDP1 4126/4885KDM4E 3796/4885HTT 1375/4885 |
| US-20180094384-A1 | OXIDATIVE METHOD | CAT, LPO, MPO | TDP1 2935/4885KDM4E 3828/4885HTT 2048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.